Qube Research & Technologies (QRT)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.4M | Sell |
151,095
-31,495
| -17% | -$9.05M | 0.04% | 359 |
|
|
2025
Q1 | $56.3M | Buy |
182,590
+72,247
| +65% | +$22.3M | 0.07% | 269 |
|
|
2024
Q4 | $38.9M | Buy |
110,343
+56,530
| +105% | +$19.9M | 0.05% | 353 |
|
|
2024
Q3 | $19.3M | Buy |
53,813
+22,118
| +70% | +$7.93M | 0.03% | 509 |
|
|
2024
Q2 | $10.1M | Sell |
31,695
-152,962
| -83% | -$48.7M | 0.02% | 737 |
|
|
2024
Q1 | $42.4M | Sell |
184,657
-20,587
| -10% | -$4.73M | 0.07% | 299 |
|
|
2023
Q4 | $45.1M | Buy |
205,244
+121,279
| +144% | +$26.7M | 0.09% | 260 |
|
|
2023
Q3 | $19M | Buy |
83,965
+4,245
| +5% | +$959K | 0.05% | 371 |
|
|
2023
Q2 | $17.6M | Sell |
79,720
-96,447
| -55% | -$21.3M | 0.06% | 346 |
|
|
2023
Q1 | $39.5M | Buy |
176,167
+31,211
| +22% | +$6.99M | 0.17% | 122 |
|
|
2022
Q4 | $40.3M | Buy |
144,956
+77,946
| +116% | +$21.7M | 0.22% | 102 |
|
|
2022
Q3 | $14M | Buy |
+67,010
| New | +$14M | 0.08% | 308 |
|
|
2022
Q2 | – | Sell |
-15,557
| Closed | -$2.79M | – | 3141 |
|
|
2022
Q1 | $2.79M | Buy |
+15,557
| New | +$2.79M | 0.02% | 680 |
|
|
2021
Q4 | – | Sell |
-66,113
| Closed | -$12.2M | – | 2990 |
|
|
2021
Q3 | $12.2M | Buy |
66,113
+51,904
| +365% | +$9.58M | 0.15% | 160 |
|
|
2021
Q2 | $2.55M | Buy |
14,209
+6,505
| +84% | +$1.17M | 0.03% | 612 |
|
|
2021
Q1 | $1.29M | Buy |
+7,704
| New | +$1.29M | 0.02% | 753 |
|
|
2020
Q4 | – | Sell |
-48,259
| Closed | -$4.87M | – | 2227 |
|
|
2020
Q3 | $4.87M | Buy |
48,259
+4,995
| +12% | +$504K | 0.07% | 362 |
|
|
2020
Q2 | $5.24M | Buy |
+43,264
| New | +$5.24M | 0.08% | 334 |
|
|
2018
Q4 | – | Sell |
-1,440
| Closed | -$184K | – | 873 |
|
|
2018
Q3 | $184K | Buy |
1,440
+1,008
| +233% | +$129K | 0.02% | 536 |
|
|
2018
Q2 | $49K | Buy |
+432
| New | +$49K | 0.03% | 528 |
|